June wave of departures in the pharmaceutical industry continues, with a number of executive changes causing concern

According to incomplete statistics, nearly 100 executives in the pharmaceutical industry have left their jobs this yearIn May, more than 10 pharmaceutical executives have resigned, including listed pharmaceutical companies well-known executives, the reasons for leaving include work reasons, personal reasons, term expiration, job division adjustment, among which for personal reasonsIn June, the wave of departures in the pharmaceutical industry continued.
Xinbang Pharmaceutical Director Resignation June 14 News, Xinbang Pharmaceutical Board of Directors on June 13, 2020 received the company's director, deputy general manager Xu Qi submitted a written resignation reportXu Qi resigned as deputy general manager and remained a director of the companyIt is understood that Xu Qi for personal work reasons to apply to resign from the company's deputy general manager.
Fu'an PharmaceuticalS director and general manager resign Recently, Fu'an Pharmaceuticals announced that the company's board of directors on June 12 received a written resignation report from Jiang Chen, director and general manager of the companyJiang Chen applied for personal reasons to resign from his position as a director, member of the strategic committee of the board of directors and general managerAfter his resignation, Jiang Chen will not hold other positions at Fu'an PharmaceuticalsJiang Chen's original term of office expires on December 20, 2021.
Before the new general manager arrives, Wang Tianxiang, chairman of the board, will temporarily perform the duties of general managerFuan Pharmaceuticals will complete the by-election of directors and the appointment of a general manager as soon as possible.
On June 11, Tianjin Lisheng Pharmaceuticals announced that, after verification, Qi Tiezhu will no longer serve as a director, chairman of the board of directors, and a member of the Strategy and Development Committee for the reasons of the change in work, and that the reasons for the change of position are consistent with the actual situationQi Tiewill will no longer hold any position in the company.
On June 10, the deputy general manager of Harpharma aghast company resigned, ha pharmaceutical shares issued a notice that the board of directors received the resignation of the company's deputy general manager Gao Lei, for personal reasons Gao Lei resigned as the company's deputy general manager, resigned from the company after the absence of any other positionAccording to the information, Gao Lei's term as deputy general manager ends on October 25, 2020.
As of March 31, 2020, four vice-presidents of Liu Gangmin, Wu Zhijun, Zhou Xing and Wei Shuangying have left their posts, with the exception of Wu Zhijun leaving for "personal reasons," according to the 2019 annual report.
On June 10, the Chairman of the Supervisory Board of Ji Pharmaceutical Holdings resigned, and Ji Pharmaceutical Holdings announced that it had received a written resignation report from MsZhao Liyuan, Chairman of the Supervisory BoardFor personal reasons, MsZhao Liyuan applied to resign as Chairman and Supervisor of the Company's Supervisory Board, and MsZhao Liyuan will continue to serve as The Human Resources Department of Jilin Jinbao Pharmaceutical Co., Ltd., a subsidiary of the company, after resigning from the above position.
Mingde Bio Deputy General Manager resigned June 5, Wuhan Mingde Bio issued a notice that recently received the company's deputy general manager, board secretary Zhou Yun written resignation report, Zhou Yun for personal reasons to apply to resign from the company's deputy general manager, the board of directors secretary, his resignation report from the date of service to the board of directors.
After resigning as deputy general manager and secretary of the board of directors, Zhou Yun will no longer hold any position in Minder BioDuring the company's failure to formally appoint a new secretary to the board of directors, the board of directors of the company appoints Wang Rui, the deputy general manager of the company, to act as secretary of the board of directors, and the company will appoint a new secretary of the board of directors as soon as possible in accordance with the relevant provisions.
Tianrui Pharmaceuticalgeneral General Manager Resigns On June 3, Guilin Tianrui Pharmaceuticals issued two announcements announcing the resignation of Zhong Ming, General Manager of the Company, and Zhao Guifang, Director and SupervisorAccording to the announcement, Zhong Ming and Zhao Guifang resigned from the above positions for personal reasonsAfter resigning, Zhong Ming continued to serve as chairman and Zhao Guifang continued to serve as supervisor.
China Pharmaceutical and Health Industry Director Resignation June 1, China Pharmaceutical And Health Industry Co., Ltdannounced that it has recently received a written resignation report from director and general manager Hou WenlingDue to job adjustment reasons, Hou Wenling applied to resign from the company's director, general manager and board of directors of the relevant positions, and will no longer hold any positions in the company.
Fosun Vice President of Pharmaceuticals resigned on June 1, Fosun Pharma announced that the board of directors received a written resignation letter from Li Jianqing For personal reasons, Li Jianqing applied to the company's board of directors to resign as vice president, and as of May 31, 2020, Li Jianqing will no longer serve as vice president of the company.
It is worth noting that three vice-presidents of Fosun Pharma have resigned so far this year On April 17, Fosun Pharma Vice President Dai Kun resigned for personal reasons, and on May 6, Fosun Pharma announced that Hequn Yin, the company's senior vice president, had resigned.